Indium in 111 capromab pendetide
Indium in 111 capromab pendetide is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
155 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 14 | 4 | 16 | 17 | 11 | 62 |
| Healthy volunteers/patients | — | 11 | — | — | 1 | 2 | 14 | ||
| Essential hypertension | D000075222 | I10 | 2 | 5 | 3 | 1 | — | 11 | |
| Heart failure | D006333 | EFO_0003144 | I50 | — | 1 | 6 | 3 | 1 | 11 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | — | 2 | 2 | 2 | 7 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | 4 | — | 5 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | 2 | 1 | 1 | 4 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | 1 | 1 | — | 3 |
| Chronic renal insufficiency | D051436 | N18 | 1 | — | — | 1 | 1 | 3 | |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | 2 | — | 3 |
Show 16 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | U07.1 | — | 2 | 2 | — | — | 3 | |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 1 | — | 1 | 3 |
| Aortic valve stenosis | D001024 | EFO_0000266 | Q25.1 | — | — | 2 | — | — | 2 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | 2 | — | — | 2 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | 1 | — | — | 1 |
| Migraine without aura | D020326 | EFO_0005296 | G43.0 | — | 1 | 1 | — | — | 1 |
| Migraine with aura | D020325 | EFO_0005295 | G43.1 | — | 1 | 1 | — | — | 1 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | — | — | 1 |
| Renovascular hypertension | D006978 | EFO_1001153 | I15.0 | — | — | 1 | — | — | 1 |
| Renal artery obstruction | D012078 | EFO_1001150 | N28.0 | — | — | 1 | — | — | 1 |
Show 1 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | G31.84 | — | 3 | — | — | — | 3 | |
| Migraine disorders | D008881 | EFO_0003821 | G43 | — | 1 | — | — | 1 | 2 |
| Peripheral nervous system diseases | D010523 | G64 | — | 1 | — | — | — | 1 | |
| Cocaine-related disorders | D019970 | F14 | — | 1 | — | — | — | 1 | |
| Cardio-renal syndrome | D059347 | 1 | 1 | — | — | — | 1 | ||
| Alcoholic liver diseases | D008108 | EFO_0008573 | K70 | 1 | 1 | — | — | — | 1 |
| Hepatitis c | D006526 | B19.2 | — | 1 | — | — | — | 1 | |
| Aging | D000375 | GO_0007568 | R41.81 | — | 1 | — | — | — | 1 |
| Hypertrophic cardiomyopathy | D002312 | EFO_0000538 | I42.1 | — | 1 | — | — | — | 1 |
| Cluster headache | D003027 | HP_0012199 | G44.00 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | 1 | — | — | — | — | 1 | ||
| Barrett esophagus | D001471 | EFO_0000280 | K22.7 | 1 | — | — | — | — | 1 |
| Hyperphosphatemia | D054559 | HP_0002905 | 1 | — | — | — | — | 1 | |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | — | 2 | 2 |
| Cardiotoxicity | D066126 | EFO_1001482 | — | — | — | — | 1 | 1 | |
| Headache | D006261 | HP_0002315 | R51 | — | — | — | — | 1 | 1 |
| Morbid obesity | D009767 | EFO_0001074 | — | — | — | — | 1 | 1 | |
| Hypoglycemia | D007003 | HP_0001943 | E16.2 | — | — | — | — | 1 | 1 |
| Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | — | 1 | 1 | |
| Angina pectoris | D000787 | EFO_0003913 | I20 | — | — | — | — | 1 | 1 |
| Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | — | 1 | 1 | |
| Cohort studies | D015331 | — | — | — | — | 1 | 1 | ||
| Diabetic nephropathies | D003928 | EFO_0000401 | — | — | — | — | 1 | 1 |
Show 4 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | INDIUM IN 111 CAPROMAB PENDETIDE |
| INN | — |
| Description | Indium in 111 capromab pendetide is an antibody pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Antibody |
| Drug class | monoclonal antibodies; peptides |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108800 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
15,517 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more